TC BioPharm
Entity

  • TC BioPharm

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    7,058

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    1, 2 Parklands Wy, Motherwell ML1 4WR, UK

    Holytown

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 56

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    10 months, 4 weeks ago
Description
  • Value proposition

    Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

    TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.

    We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations.

    Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

  • Home • TC BioPharm

    TC BioPharm (Nasdaq: TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer.

    • https://tcbiopharm.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics